Sl. No:

Title

Granted Country

Grant No:

Grant Date

Licensed out

1

Methods and materials for identifying therapeutic response in chronic myeloid leukemia.

USPTO

10,466,244 B2

November 5, 2020

No

2

A mouthwash composition for managing oral mucositis, process and methods thereof.

INDIA

350995

November 5, 2020

YES

3

Polypeptides for managing viral infections.

USPTO

10898544

January 26,2021

No

4

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma.

JAPAN

6830153

January 27,2021

YES

5

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma.

CANADA

3026426

April 13,2021

YES

6

Polypeptides for managing viral infections.

EUROPE

EP3554533

June 9, 2021

NO

7

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma.

SOUTH KOREA

10-2293156

August 18,2021

YES

8

Methods and materials for identifying therapeutic response in chronic myeloid leukemia.

INDIA

422187

February 17,2023

NO

9

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma

USPTO

11607422

March 21,2023

YES

10

Polypeptides for Managing Viral Infections

USPTO

11666630

June 06, 2023

NO

11

Synthetic Transmembrane Peptide Pores for the Single-Molecule Sensing

INDIA

407575

September 26, 2022

NO

12

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma

Europe

EP3463382

August 30, 2023

YES

13

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma

USPTO

11,738,036

August 29,2023

YES